Aisling Capital Management

Latest statistics and disclosures from Aisling Capital Management's latest quarterly 13F-HR filing:

Companies in the Aisling Capital Management portfolio as of March 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Eidos Therapeutics Inc 20.07 1.12M 23.45
Avrobio Ord 13.64 811998 +10% 22.05
Obseva Sa 13.50 1.39M 12.79
Biohaven Pharmaceutical Holding 10.76 274513 51.47
Marker Therapeutics Ord 10.05 2.00M 6.60
Aeglea Biotherapeutics 7.48 1.22M +40% 8.05
Sunesis Pharmaceuticals Inc Ne 7.06 7.60M +192% 1.22
Zosano Pharma Corp 5.81 1.60M 4.77
Nabriva Therapeutics 3.36 1.81M 2.44
Arcus Biosciences Incorporated 3.17 333333 -37% 12.49
Aclaris Therapeutics 2.89 634455 5.99
Verona Pharma Plc ads 2.20 443596 6.50

Past 13F-HR SEC Filings by Aisling Capital Management

View All Filings